Northern Trust
KYNB

Northern Trust’s Kyntra Bio KYNB Stock Holding History

Northern Trust’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,852
Closed -$113K – 4448
2025
Q4 		$113K Buy
+12,852
New +$126K ﹤0.01% 4117
2025
Q2 		– Sell
-7,115
Closed -$55.1K – 4434
2025
Q1 		$55.1K Buy
7,115
+5
+0.1% +$60 ﹤0.01% 4221
2024
Q4 		$94.1K Buy
7,110
+32
+0.5% +$297 ﹤0.01% 4164
2024
Q3 		$70.7K Sell
7,078
-20,383
-74% -$308K ﹤0.01% 4135
2024
Q2 		$613K Sell
27,461
-2,799
-9% -$86.5K ﹤0.01% 3430
2024
Q1 		$1.78M Sell
30,260
-838
-3% -$36.1K ﹤0.01% 3026
2023
Q4 		$689K Buy
31,098
+1,491
+5% +$22.5K ﹤0.01% 3437
2023
Q3 		$639K Sell
29,607
-4,062
-12% -$160K ﹤0.01% 3445
2023
Q2 		$2.27M Buy
33,669
+222
+0.7% +$91.8K ﹤0.01% 2939
2023
Q1 		$15.6M Buy
33,447
+692
+2% +$366K ﹤0.01% 1715
2022
Q4 		$13.1M Buy
32,755
+819
+3% +$314K ﹤0.01% 1824
2022
Q3 		$10.4M Sell
31,936
-254
-0.8% -$81.8K ﹤0.01% 1941
2022
Q2 		$8.5M Sell
32,190
-1,696
-5% -$433K ﹤0.01% 2148
2022
Q1 		$10.2M Sell
33,886
-2,555
-7% -$891K ﹤0.01% 2135
2021
Q4 		$12.8M Buy
36,441
+1,512
+4% +$471K ﹤0.01% 2065
2021
Q3 		$8.92M Sell
34,929
-1,171
-3% -$415K ﹤0.01% 2365
2021
Q2 		$24M Sell
36,100
-2,348
-6% -$1.35M ﹤0.01% 1760
2021
Q1 		$33.4M Sell
38,448
-3,263
-8% -$3.47M 0.01% 1453
2020
Q4 		$38.7M Sell
41,711
-1,451
-3% -$1.53M 0.01% 1285
2020
Q3 		$44.4M Buy
43,162
+649
+2% +$698K 0.01% 1004
2020
Q2 		$43.1M Buy
42,513
+1,145
+3% +$1.06M 0.01% 1003
2020
Q1 		$35.9M Buy
41,368
+439
+1% +$436K 0.01% 990
2019
Q4 		$43.9M Sell
40,929
-389
-0.9% -$397K 0.01% 1115
2019
Q3 		$38.2M Buy
41,318
+1,515
+4% +$1.66M 0.01% 1180
2019
Q2 		$45M Buy
39,803
+2,290
+6% +$2.51M 0.01% 1078
2019
Q1 		$51M Buy
37,513
+750
+2% +$1.02M 0.01% 952
2018
Q4 		$42.5M Buy
36,763
+80
+0.2% +$89.9K 0.01% 987
2018
Q3 		$55.7M Buy
36,683
+552
+2% +$850K 0.01% 920
2018
Q2 		$56.5M Buy
36,131
+2,893
+9% +$3.77M 0.01% 893
2018
Q1 		$38.4M Sell
33,238
-249
-0.7% -$328K 0.01% 1191
2017
Q4 		$39.7M Buy
33,487
+495
+2% +$621K 0.01% 1170
2017
Q3 		$44.4M Buy
32,992
+3,613
+12% +$3.81M 0.01% 1053
2017
Q2 		$23.7M Buy
29,379
+3,699
+14% +$2.58M 0.01% 1546
2017
Q1 		$15.8M Buy
25,680
+1,227
+5% +$747K ﹤0.01% 1795
2016
Q4 		$13.1M Buy
24,453
+363
+2% +$181K ﹤0.01% 1913
2016
Q3 		$12.5M Buy
24,090
+260
+1% +$122K ﹤0.01% 1916
2016
Q2 		$9.78M Buy
23,830
+2,230
+10% +$1.02M ﹤0.01% 2042
2016
Q1 		$11.5M Buy
21,600
+474
+2% +$236K ﹤0.01% 1874
2015
Q4 		$16.1M Buy
21,126
+648
+3% +$430K 0.01% 1656
2015
Q3 		$11.2M Buy
20,478
+15,520
+313% +$9.4M ﹤0.01% 1917
2015
Q2 		$2.91M Buy
4,958
+1,296
+35% +$754K ﹤0.01% 2857
2015
Q1 		$2.87M Buy
3,662
+19
+0.5% +$14.7K ﹤0.01% 2876
2014
Q4 		$2.49M Buy
+3,643
New +$2.34M ﹤0.01% 2956

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust's KYNB Position: Q1 2026 in Review

Northern Trust sold out of Kyntra Bio (KYNB) in Q1 2026, closing a stake of 12,852 shares — an estimated $113K sold.

Northern Trust first reported a position in KYNB in Q4 2014 and held it in 43 quarters. The position peaked at $56.5M in Q2 2018. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Northern Trust reported no remaining Kyntra Bio position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 12,852 Kyntra Bio shares in Q1 2026, an estimated $113K.
  • Northern Trust first reported a position in Kyntra Bio in Q4 2014 and held it in 43 quarters.
  • Northern Trust's Kyntra Bio position peaked at $56.5M in Q2 2018.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.